|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07H 21/02 | |
| A61K 31/713 | |||
| C12N 15/113 |
| (11) | Number of the document | 2341943 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09814902.4 |
| Date of filing the European patent application | 2009-09-17 | |
| (97) | Date of publication of the European application | 2011-07-13 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/005214 |
| Date | 2009-09-17 |
| (87) | Number | WO 2010/033225 |
| Date | 2010-03-25 |
| (30) | Number | Date | Country code |
| 136741 P | 2008-09-22 | US | |
| 136736 P | 2008-09-22 | US |
| (72) |
BROWN, Bob, US
|
| (73) |
Dicerna Pharmaceuticals, Inc.,
87 Cambridgepark Drive, Cambridge, MA 02140,
US
|
| (54) | COMPOSITIONS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DSRNA POSSESSING MODIFICATIONS |
| COMPOSITIONS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DSRNA POSSESSING MODIFICATIONS |